Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.45
(-3.23%)
AUD 0.45
(-3.23%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 21.68 Million AUD | 26.75% |
| 2023 | 17.1 Million AUD | 22.53% |
| 2022 | 13.96 Million AUD | -7.34% |
| 2021 | 15.06 Million AUD | 189.4% |
| 2020 | 5.2 Million AUD | 54.83% |
| 2019 | 3.36 Million AUD | 17.29% |
| 2018 | 2.86 Million AUD | -9.23% |
| 2017 | 3.15 Million AUD | -34.25% |
| 2016 | 4.8 Million AUD | 961.46% |
| 2015 | 452.64 Thousand AUD | 46.81% |
| 2014 | 308.31 Thousand AUD | 18.97% |
| 2013 | 259.15 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 21.68 Million AUD | 26.75% |
| 2024 Q2 | 9.41 Million AUD | 0.0% |
| 2024 Q4 | 12.27 Million AUD | 0.0% |
| 2023 Q2 | 9.17 Million AUD | 0.0% |
| 2023 Q4 | 7.92 Million AUD | 0.0% |
| 2023 FY | 17.1 Million AUD | 22.53% |
| 2022 Q4 | 9.04 Million AUD | 0.0% |
| 2022 FY | 13.96 Million AUD | -7.34% |
| 2022 Q2 | 4.92 Million AUD | 0.0% |
| 2021 Q2 | 10.82 Million AUD | 0.0% |
| 2021 FY | 15.06 Million AUD | 189.4% |
| 2021 Q4 | 4.24 Million AUD | 0.0% |
| 2020 FY | 5.2 Million AUD | 54.83% |
| 2020 Q4 | 2.94 Million AUD | 0.0% |
| 2020 Q2 | 2.26 Million AUD | 0.0% |
| 2019 FY | 3.36 Million AUD | 17.29% |
| 2019 Q2 | 1.34 Million AUD | 0.0% |
| 2019 Q4 | 1.68 Million AUD | 0.0% |
| 2018 Q2 | 1.24 Million AUD | 0.0% |
| 2018 FY | 2.86 Million AUD | -9.23% |
| 2018 Q4 | 1.27 Million AUD | 0.0% |
| 2017 Q4 | 1.14 Million AUD | 0.0% |
| 2017 FY | 3.15 Million AUD | -34.25% |
| 2017 Q2 | 1 Million AUD | 0.0% |
| 2016 FY | 4.8 Million AUD | 961.46% |
| 2016 Q4 | 742.82 Thousand AUD | 0.0% |
| 2016 Q2 | 4.03 Million AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 FY | 452.64 Thousand AUD | 46.81% |
| 2015 Q2 | 101.67 Thousand AUD | 0.0% |
| 2015 Q4 | 350.97 Thousand AUD | 0.0% |
| 2014 FY | 308.31 Thousand AUD | 18.97% |
| 2013 FY | 259.15 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 45.206% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -2953.217% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -264.536% |
| Biome Australia Limited | 7.91 Million AUD | -174.098% |
| Patrys Limited | 4.93 Million AUD | -339.552% |
| Orthocell Limited | 15.36 Million AUD | -41.087% |
| Imugene Limited | 135.09 Million AUD | 83.948% |
| Noxopharm Limited | 7 Million AUD | -209.77% |
| PYC Therapeutics Limited | 60.91 Million AUD | 64.403% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -9.699% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -98.962% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -2330.605% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -94.942% |
| CSL Limited | 7.56 Billion AUD | 99.713% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -101.056% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -685.381% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 30.714% |
| Starpharma Holdings Limited | 22.81 Million AUD | 4.959% |
| Nanollose Limited | 12.5 Thousand AUD | -173361.875% |
| Memphasys Limited | 3.67 Million AUD | -489.511% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -548.094% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -1003.411% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -157.055% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -3503.149% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -425.639% |
| Race Oncology Limited | 14.77 Million AUD | -46.81% |
| Nyrada Inc. | 4.55 Million AUD | -376.041% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 91.947% |
| Dimerix Limited | 25.64 Million AUD | 15.438% |
| PharmAust Limited | 6.65 Million AUD | -225.74% |
| Immutep Limited | 42.87 Million AUD | 49.424% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 61.489% |
| Alterity Therapeutics Limited | 23.4 Million AUD | 7.358% |
| BTC Health Limited | -1.03 Million AUD | 2187.199% |
| Acrux Limited | 8.55 Million AUD | -153.62% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 33.681% |
| Biotron Limited | 5.11 Million AUD | -324.298% |
| Tissue Repair Ltd | 6.66 Million AUD | -225.26% |
| AdAlta Limited | 6.76 Million AUD | -220.326% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -7146.805% |
| Hexima Limited | 1 Million AUD | -2049.638% |
| AnteoTech Limited | 12.18 Million AUD | -77.931% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 66.692% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -377.065% |
| Actinogen Medical Limited | 22.77 Million AUD | 4.769% |
| Immuron Limited | 9.13 Million AUD | -137.302% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -162.234% |